MedTrace Logo

Acceptance of a Partially Hydrolyzed Formula

NCT05245422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2025-06-18

No results posted yet for this study

Summary

A multi-center, double-blind, controlled, parallel-designed, prospective trial intended to evaluate the nutritive effects of a partially hydrolyzed cow's milk protein infant formula on infant fussiness.

Conditions

  • Fussy Infant (Baby)

Interventions

OTHER

Infant Formula - Partially hydrolyzed protein

Partially hydrolyzed cow's milk protein

OTHER

Infant Formula - Intact protein

Intact cow's milk protein

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Days
Max Age
75 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2023-07-14
Completion
2023-07-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05245422 on ClinicalTrials.gov